With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030 ...

TD Cowen lowered the firm’s price target on Novo Nordisk (NVO) to $105 from $155 and keeps a Buy rating on the shares.Pick the best stocks and maximize your portfolio:Discover top-rated stocks ...

The average one-year price target for Novo Nordisk A (NYSE:NVO) has been revised to 119.21 / share. This is an increase of 6.93% from the prior estimate of 111.49 dated January 18, 2024.

Novo Nordisk A/S (NYSE: NVO) is one of the high-margin pharma stocks to buy now. Berenberg has reaffirmed its Hold rating on ...

Eli Lilly and Novo Nordisk are currently the only drugmakers with FDA approved weight-loss medicines on the U.S. market.

On Thursday, BMO Capital Markets adjusted its stance on Novo Nordisk (NYSE: NVO) stock, downgrading it from ’Outperform’ to ’Market Perform’.Alongside the rating change, the firm significantly reduced ...

Deutsche Bank analyst Emmanuel Papadakis lowered the firm’s price target on Novo Nordisk (NVO) to DKK 900 from DKK 1,000 and keeps a Buy rating on the shares. Published first on TheFly – the ...

Novo Nordisk (NVO-2.44%) ... He also maintained his price target of 425 Danish Kroner ($60.94) per share on the European pharmaceutical company.

On Wednesday, BofA Securities revised its price target for Novo Nordisk (NOVOB:DC) (NYSE: NYSE: NVO) shares, lowering it to DKK850 from the previous DKK910.Despite the reduction, the firm ...

Ozempic, the blockbuster diabetes shot made by Novo Nordisk A/S, is “very likely” to be one of the next drugs targeted for a price cut in bargaining with the US government’s Medicare program ...

The former upped his price target on Novo Nordisk to 800 Danish kroner ($115) per share from the previous 750 kroner ($108), while the latter raised his to 730 kroner ($105) from 705 kroner ($101).

TD Cowen lowered the firm’s price target on Novo Nordisk (NVO) to $105 from $155 and keeps a Buy rating on the shares. Published first on TheFly – the ultimate source for real-time, market ...